| PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease B Zheng, Z Liao, JJ Locascio, KA Lesniak, SS Roderick, ML Watt, ... Science translational medicine 2 (52), 52ra73-52ra73, 2010 | 774 | 2010 |
| Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans N Striepens, KM Kendrick, V Hanking, R Landgraf, U Wüllner, W Maier, ... Scientific reports 3 (1), 1-5, 2013 | 459 | 2013 |
| Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains A Jowaed, I Schmitt, O Kaut, U Wüllner Journal of Neuroscience 30 (18), 6355-6359, 2010 | 402 | 2010 |
| Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients JR Bedarf, F Hildebrand, LP Coelho, S Sunagawa, M Bahram, F Goeser, ... Genome medicine 9 (1), 1-13, 2017 | 389 | 2017 |
| Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease P Koch, P Breuer, M Peitz, J Jungverdorben, J Kesavan, D Poppe, J Doerr, ... Nature 480 (7378), 543-546, 2011 | 334 | 2011 |
| Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease S Paus, HM Brecht, J Köster, G Seeger, T Klockgether, U Wüllner Movement Disorders 18 (6), 659-667, 2003 | 334 | 2003 |
| SNCA variants are associated with increased risk for multiple system atrophy SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 293 | 2009 |
| Multiple regions of α‐synuclein are associated with Parkinson's disease JC Mueller, J Fuchs, A Hofer, A Zimprich, P Lichtner, T Illig, D Berg, ... Annals of neurology 57 (4), 535-541, 2005 | 263 | 2005 |
| Induction of nitric oxide synthase and nitric oxide‐mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor‐α/lipopolysaccharide MT Heneka, PA Löschmann, M Gleichmann, M Weller, JB Schulz, ... Journal of neurochemistry 71 (1), 88-94, 1998 | 250 | 1998 |
| Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function U Wüllner, J Seyfried, P Groscurth, S Beinroth, S Winter, M Gleichmann, ... Brain research 826 (1), 53-62, 1999 | 227 | 1999 |
| Mutations in COQ2 in Familial and Sporadic Multiple-System Atrophy Multiple-System Atrophy Research Collaboration New England Journal of Medicine 369 (3), 233-244, 2013 | 225 | 2013 |
| Extracellular phosphorylation of the amyloid β‐peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease S Kumar, N Rezaei‐Ghaleh, D Terwel, DR Thal, M Richard, M Hoch, ... The EMBO journal 30 (11), 2255-2265, 2011 | 215 | 2011 |
| Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide … MT Heneka, DL Feinstein, E Galea, M Gleichmann, U Wüllner, ... Journal of neuroimmunology 100 (1-2), 156-168, 1999 | 208 | 1999 |
| Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. U Wüllner, PA Löschmann, JB Schulz, A Schmid, R Dringen, F Eblen, ... Neuroreport 7 (4), 921-923, 1996 | 204 | 1996 |
| Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study T Schmitz‐Hübsch, D Pyfer, K Kielwein, R Fimmers, T Klockgether, ... Movement disorders: official journal of the Movement Disorder Society 21 (4 …, 2006 | 192 | 2006 |
| An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis A Boeddrich, S Gaumer, A Haacke, N Tzvetkov, M Albrecht, BO Evert, ... The EMBO journal 25 (7), 1547-1558, 2006 | 191 | 2006 |
| Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination I Schmitt, M Linden, H Khazneh, BO Evert, P Breuer, T Klockgether, ... Biochemical and biophysical research communications 362 (3), 734-739, 2007 | 169 | 2007 |
| Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation BO Evert, J Araujo, AM Vieira-Saecker, RAI de Vos, S Harendza, ... Journal of Neuroscience 26 (44), 11474-11486, 2006 | 169 | 2006 |
| Structural and functional analysis of ataxin‐2 and ataxin‐3 M Albrecht, M Golatta, U Wüllner, T Lengauer European journal of biochemistry 271 (15), 3155-3170, 2004 | 166 | 2004 |
| Bright light therapy in Parkinson's disease: a pilot study S Paus, T Schmitz‐Hübsch, U Wüllner, A Vogel, T Klockgether, M Abele Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007 | 155 | 2007 |
P.-A. LoeschmannVerified email at loeschmann.de
